Life Science Analytics Market Report 2025

This Life Science Analytics market report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The life science analytics market size has grown rapidly in recent years. It will grow from $28.56 billion in 2024 to $31.49 billion in 2025 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to pharmaceutical sales and marketing, healthcare cost reduction, global health preparedness, biopharmaceutical manufacturing, digital health adoption.

The life science analytics market size is expected to see rapid growth in the next few years. It will grow to $56.92 billion in 2029 at a compound annual growth rate (CAGR) of 15.9%. The growth in the forecast period can be attributed to adoption of telemedicine, growth of population, adoption of drug repurposing, regulatory reforms, increasing disease surveillance. Major trends in the forecast period include artificial intelligence (ai)-enhanced drug safety, predictive analytics in diagnostics, gene editing advancements, data visualization tools, blockchain for data security.

The growth of the life science analytics market is anticipated to be propelled by the increasing prevalence of chronic diseases. Chronic diseases, characterized by long-term persistence, necessitate advanced analytics for early detection and intervention. Predictive analytics, a component of life science analytics, plays a crucial role in chronic disease prevention. According to the International Diabetes Federation (IDF), the global diabetic population reached approximately 537 million adults in 2021, with projections indicating an increase to 643 million by 2030 and 783 million by 2045. This escalating prevalence of chronic diseases is a key factor driving the expansion of the life science analytics market.

The life science analytics market is expected to experience growth due to the rising demand for personalized medicine. Personalized medicine tailors medical treatments to an individual's unique genetic makeup, enhancing the effectiveness and precision of healthcare interventions. Life science analytics are integral to personalized medicine for various purposes, including drug discovery, biomarker identification, genomic and molecular data analysis, and clinical decision support. In 2022, the Food and Drug Administration’s Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs), with approximately 34% classified as personalized medicines, according to the Personalized Medicine Coalition. This surge in demand for personalized medicine is a significant driver of the life science analytics market.

A prominent trend in the life science analytics market is the adoption of technological advancements. Major companies in the sector are actively developing new technological solutions to strengthen their market position. For example, Charles River Associates introduced the healthcare claims analytics platform (HCAP) in July 2022. HCAP, a dynamic and modular data visualization tool, streamlines the analysis of patient, healthcare practitioner (HCP), and healthcare organization (HCO) data, enabling informed decision-making through insights and analytics. This focus on technological innovation is shaping the landscape of the life science analytics market.

Leading companies in the life science analytics market are concentrating on developing innovations using advanced analytics technologies, such as artificial intelligence, to gain a competitive advantage. AI in life sciences analytics is employed to enhance data analysis, streamline drug discovery processes, optimize clinical trials, and facilitate personalized medicine by revealing insights from complex biological data. For example, in September 2023, SAS Health, a healthcare technology company based in India, launched a groundbreaking healthcare platform designed to simplify health data management, improve data governance, and expedite patient insights. This comprehensive enterprise solution for analytics and data automation will provide healthcare providers, insurers, and public health agencies with the agility needed to foster innovations that enhance patient experiences and outcomes. Utilizing a unified health data model with mappings to industry standards, SAS Health will support the proactive identification of clinical staffing gaps and visualization of screening centers in relation to patient populations. Powered by the SAS Viya AI platform, it offers rapid access to actionable insights while ensuring compliance with regulations.

In July 2022, Trinity Life Sciences strategically acquired D Cube Analytics, a healthcare analytics company based in Illinois, for an undisclosed amount. This acquisition enhances Trinity's product offerings by incorporating extensive data science and digital transformation capabilities. The move underscores the significance of data analytics in the evolving landscape of life sciences commercialization services.

Major companies operating in the life science analytics market include Oracle Corporation., Accenture plc., SAS Institute Inc., International Business Machines Corporation (IBM), IQVIA Holdings Inc., Wipro Limited, Cognizant Technology Solutions Corporation, SCIOInspire Corp., Cerner Corporation, Optum Inc., Microsoft Corporation, MaxisIT Inc., Cotiviti Holdings Inc., Allscripts Healthcare Solutions Inc., ExlService Holdings Inc., Inovalon Holdings Inc., CitiusTech Inc., Saama Technologies LLC., Axtria Inc., Clarivate Plc, ThoughtSphere Ltd., ThoughtSpot Inc., Alteryx Inc., TAKE Solutions Ltd., Dynata LLC., M3 EU Ltd., BioSymetrics Inc., PerkinElmer Inc., Medidata Solutions Inc., PAREXEL International Corporation.

North America was the largest region in the life science analytics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the life science analytics market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the life science analytics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Life science analytics is a field dedicated to the study and advancement of human life, playing a crucial role in comprehending diseases' nature and severity. It involves clinical data analysis, offering predictive tools to enhance patient care and safeguard both animal and human well-being.

Within the life science market, there are three primary types of analytics: descriptive, predictive, and prescriptive. Descriptive analytics involves manually examining data to answer questions about what has happened or is currently occurring. It encompasses traditional business intelligence tools like bar charts, pie charts, line graphs, tables, and narrative generation. This analytical approach utilizes software and services and can be deployed on-demand or on-premises. Its applications span across research and development, preclinical and clinical trials, sales and marketing, regulatory compliance, supply chain optimization, and pharmacovigilance. Various end-users, including medical devices, pharmaceuticals, biotechnology, and others, benefit from these analytics.

The life science analytics market research report is one of a series of new reports that provides life science analytics market statistics, including life science analytics industry global market size, regional shares, competitors with a life science analytics market share, detailed life science analytics market segments, market trends and opportunities, and any further data you may need to thrive in the life science analytics industry. This life science analytics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The life science analytics market includes revenues earned by entities by reporting, diagnostic and discovery. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.